Accedi

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.

Unlike nondepolarizing blockers, succinylcholine, a depolarizing blocker, has more severe adverse effects, including hyperkalemia, arrhythmia, postoperative muscle pain, increased intraocular pressure, and regurgitation of gastric content due to increased gastric pressure.

Adverse effects of directly acting agents like botulinum toxin and dantrolene include general muscle weakness and hepatotoxicity. Additionally, botulinum toxin can cause respiratory tract infections and loss of bladder control.

Lastly, centrally acting muscle relaxants, which affect the central nervous system or CNS, induce various symptoms of CNS depression. For example, tizanidine causes drowsiness, hypotension, dizziness, dry mouth, and hepatotoxicity, whereas diazepam causes anxiety, tremors, insomnia, and hallucinations. Avoiding high drug doses from being given to at-risk patients such as epileptic patients or pregnant women may help reduce the severity of the side effects.

Tags
Skeletal Muscle RelaxantsAdverse EffectsMuscle ParalysisNondepolarizing Neuromuscular BlockersHypotensionBaclofenSpastic ConditionsSuccinylcholineHyperkalemiaArrhythmiaPostoperative Muscle PainBotulinum ToxinDantroleneCNS DepressionTizanidineDiazepamHepatotoxicity

Dal capitolo 7:

article

Now Playing

7.9 : Skeletal Muscle Relaxants: Adverse Effects

Skeletal Muscle Relaxants

302 Visualizzazioni

article

7.1 : Giunzione Neuromuscolare E Blocco

Skeletal Muscle Relaxants

2.6K Visualizzazioni

article

7.2 : Classificazione dei miorilassanti scheletrici

Skeletal Muscle Relaxants

2.3K Visualizzazioni

article

7.3 : Bloccanti neuromuscolari non depolarizzanti (competitivi): meccanismo d'azione

Skeletal Muscle Relaxants

1.2K Visualizzazioni

article

7.4 : Bloccanti neuromuscolari non depolarizzanti (competitivi): azioni farmacologiche

Skeletal Muscle Relaxants

342 Visualizzazioni

article

7.5 : Bloccanti neuromuscolari non depolarizzanti (competitivi): farmacocinetica

Skeletal Muscle Relaxants

403 Visualizzazioni

article

7.6 : Bloccanti depolarizzanti: meccanismo d'azione

Skeletal Muscle Relaxants

995 Visualizzazioni

article

7.7 : Bloccanti depolarizzanti: Farmacocinetica

Skeletal Muscle Relaxants

277 Visualizzazioni

article

7.8 : Miorilassanti ad azione diretta: Dantrolene e Tossina botulinica

Skeletal Muscle Relaxants

596 Visualizzazioni

article

7.10 : Miorilassanti scheletrici: usi terapeutici

Skeletal Muscle Relaxants

430 Visualizzazioni

article

7.11 : Agenti spasmolitici: classificazione chimica

Skeletal Muscle Relaxants

824 Visualizzazioni

article

7.12 : Miorilassanti ad azione periferica e centrale: un confronto

Skeletal Muscle Relaxants

2.9K Visualizzazioni

article

7.13 : Miorilassanti ad azione centrale: usi terapeutici

Skeletal Muscle Relaxants

549 Visualizzazioni

JoVE Logo

Riservatezza

Condizioni di utilizzo

Politiche

Ricerca

Didattica

CHI SIAMO

Copyright © 2025 MyJoVE Corporation. Tutti i diritti riservati